Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-depth Study of the Cost-effectiveness of the Risk Assessment and Management Programme for Hypertension (RAMP-HT) for Patients With Uncontrolled Hypertension in Primary Care in Hong Kong

NCT03301194 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03301194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-depth Study of the Cost-effectiveness of the Risk Assessment and Management Programme for Hypertension (RAMP-HT) for Patients With Uncontrolled Hypertension in Primary Care in Hong Kong
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
August 1, 2016
Completion date
January 31, 2019
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cost effectiveness, hypertension